Form 4: TransDigm Group Executive Joel Reiss Executes Stock Options and Sells Shares
SEC Form 4 Filing
TransDigm Group's Co-Chief Operating Officer, Joel Reiss, exercised stock options and sold a portion of his holdings on November 20, 2024.
Summary
- Joel Reiss, Co-Chief Operating Officer of TransDigm Group, exercised 3,000 stock options at a price of $226.34 per share on November 20, 2024.
- On the same day, Reiss sold a total of 3,000 shares of common stock at varying weighted average prices ranging from $1,250.9047 to $1,264.58.
- The sales were executed in multiple transactions, with the number of shares sold at each price point detailed in the document.
- Following these transactions, Reiss directly owns 3,600 shares of common stock and 15,550 stock options.
Sentiment
Score: 5
Explanation: The document is a neutral report of insider trading activity, with no indication of positive or negative sentiment.
Industry Context
This is a routine filing related to insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
- The transactions are typical for executives who receive stock options as part of their compensation packages.
- The weighted average prices are within the normal range for market transactions.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they represent a small portion of the total outstanding shares.
- The sales may slightly increase the supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 09/30/2016 | Date of grant for some of the stock options. |
| 10/31/2024 | Date of grant for some of the stock options. |
| 11/06/2025 | Expiration date for some of the stock options. |
| 11/20/2024 | Date of stock option exercise and share sales. |
| 10/31/2034 | Expiration date for some of the stock options. |
Keywords
TransDigm Group, Joel Reiss, stock options, share sales, insider trading, Form 4, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.